Research Shows New Genetic Risk Factors for Osteoarthritis

Photo of author

(Newswire.net — June 20, 2022) Orlando, FL — Years of research have shown the various aspects of osteoarthritis, including a person’s likelihood of getting the condition.

A study has shown new genetic risk factors and novel drug targets for osteoarthritis. The finding of this research can be counted as a milestone toward the development of the first-ever cure for the condition. 

This research, which involved an international consortium, was spearheaded by Helmholtz Zentrum München along with an international team of researchers.

This disease called osteoarthritis affects the joints and happens to more than 300 million people around the globe. It is characterized by the gradual deterioration of the joint cartilage surface and leads to chronic pain and stiffness in the joints.

It is worth being warned that this condition is actually the top cause of disability and is behind an increasing rate of unemployment. 

While there is no known treatment for this condition yet, it is worth mentioning that it is manageable. 

The investigators were able to discover new genetic risk factors for the condition and even identified high-value drug targets. The research offers a stepping stone for the translation of genetic discoveries into the development of osteoarthritis drugs. 

This, according to experts, may help catalyze an improvement in the lives of those suffering from the condition. 

“This is a major step forward in understanding this debilitating disease and could not have been achieved without this international team effort,” said Eleftheria Zeggini.

Zeggini is the Director of the Institute of Translational Genomics at Helmholtz Zentrum München and a professor at the Technical University of Munich.

It is further worth mentioning that the researchers have also found formerly unknown differences in disease risk for both weight-bearing and non-weight-bearing joints, as well as for the first-ever female-specific risk factors for developing disease and the first risk factors for early-onset disease. 

As the rates of osteoarthritis continue to soar, more and more experts are carrying out studies to look into the remedies helpful for the condition. 

It is important to note that aside from dietary and lifestyle improvements combined with the use of pain relievers, it may also be helpful to resort to the use of all-natural remedies like glucosamine.

Years of research have revealed that glucosamine helps repair joint cartilage damage and produces pain-relieving benefits. Today, it is not just used by OA sufferers but also athletes. 

One of the widely resorted-to formulas today is VitaBreeze Glucosamine, which is known for its high potency and purity. (www.amazon.com/Glucosamine-Chondroitin-Turmeric-Dietary-Supplement/dp/B00DUMO9X4)

About VitaBreeze

VitaBreeze is a nutraceutical brand that manufactures high-quality natural supplements to help people live a healthy, enjoyable, and longer life. All of the company’s products are manufactured in the United States using the finest-quality ingredients that have been carefully selected, tested, and crafted into the firm’s winning formulas. Visit http://www.VitaBreeze.com to learn more.

VitaBreeze

4700 Millenia Blvd
Suite 175 F
Orlando, FL 32839
United States
4075452239
media@vitabreeze.com
http://www.vitabreeze.com/